Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label StudyFrancesco Di Pierro, Sagheer Ahmed, Giuseppe Derosa et al.|International Journal of General Medicine|2021Cited by 183
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical TrialFrancesco Di Pierro, Saeed Khan, Somia Iqtadar et al.|International Journal of General Medicine|2021Cited by 177
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trialFrancesco Di Pierro, Nicola Zerbinati, Amjad Khan et al.|Frontiers in Pharmacology|2023Cited by 54
The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588Massimiliano Cazzaniga, Alexander Bertuccioli, Francesco Di Pierro et al.|Microorganisms|2024Cited by 15
The Potential Role of Probiotics, Especially Butyrate Producers, in the Management of Gastrointestinal Mucositis Induced by Oncologic Chemo-RadiotherapyMassimiliano Cazzaniga, Alexander Bertuccioli, Marco Cardinali et al.|International Journal of Molecular Sciences|2024Cited by 13